United Therapeutics (NASDAQ:UTHR) Announces Earnings Results, Misses Expectations By $1.18 EPS
United Therapeutics (NASDAQ:UTHR – Get Free Report) issued its earnings results on Wednesday. The biotechnology company reported $5.82 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.00 by ($1.18), FiscalAI reports. The firm had revenue of $781.50 million during the quarter, compared to analysts’ expectations of $797.40 million. United Therapeutics had […]
6 May 15:04 · The Cerbat Gem